ReviewCurrent opinion in endocrinology, diabetes, and obesity2017
Growth in patients with type 1 diabetes.
Review in Current opinion in endocrinology, diabetes, and obesity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Harnessing Machine Learning, a Subset of Artificial Intelligence, for Early Detection and Diagnosis of Type 1 Diabetes: A Systematic Review.International journal of molecular sciences · 2025Pooled it
- Final height in children and adolescents with type 1 diabetes mellitus: A systematic review and meta-analysis.Hormones (Athens, Greece) · 2024Pooled it
- Altered cortical bone strength and lean mass in young women with long-duration (19 years) type 1 diabetes.Scientific reports · 2020Trial
- Macrophage metabolic reprogramming during dietary stress influences adult body size in Drosophila.EMBO reports · 2025Article
- Glycemic Control and Adult Height: A Nationwide Swedish Cohort Study on Childhood Type 1 Diabetes.The Journal of clinical endocrinology and metabolism · 2025Article
- Mauriac Syndrome in Sudanese Children: An Old Syndrome Still Existing in Resource-Limited Countries.Pediatric diabetes · 2025Article
- Nutritional status and extended metabolic screening in Egyptian children with uncomplicated type 1 diabetes.Scientific reports · 2024Article
- Living with type 1 diabetes and schooling among young people in Ghana: a truism of health selection, inadequate support, or artefactual explanation of educational inequalities?BMC public health · 2024Article
- Diet and Glycemic Index in Children with Type 1 Diabetes.Nutrients · 2023Review
- Role of glucose variability on linear growth in children with type 1 diabetes.Endocrine connections · 2023Article
- ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes in adolescence.Pediatric diabetes · 2022Review
- Anthropometric Measurements and Laboratory Investigations in Children and Youth With Type 1 Diabetes Before and During the COVID-19 Pandemic.Canadian journal of diabetes · 2022Article
- Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis.Endocrine connections · 2022Article
- The implications of hyperoxia, type 1 diabetes and sex on cardiovascular physiology in mice.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
purpose of reviewAs the incidence of type 1 diabetes (T1DM) continues to rise, complications including impairment of childhood growth remain a major concern. This review provides an overview of alterations in growth patterns before and after the onset of T1DM. RECENT
findingsRecent advances in this field include several prospective investigations of height and weight trajectories in children leading up to the development of islet autoimmunity and T1DM as well as evaluations of larger cohorts of T1DM patients to better assess predictors of altered growth. In addition, genetic and metabolic investigations have improved our understanding of the more rare severe growth impairment of Mauriac Syndrome. SUMMARY: Despite advances in medical care of children with T1DM, growth remains suboptimal in this population and likely reflects ongoing metabolic derangement linked with classic microvascular diabetic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.